Caffeine as a protective factor in dementia and Alzheimer's disease
- PMID: 20182054
- DOI: 10.3233/JAD-2010-1404
Caffeine as a protective factor in dementia and Alzheimer's disease
Abstract
Caffeine has well-known short-term stimulating effects on central nervous system, but the long-term impacts on cognition have been less clear. Dementia and Alzheimer's disease (AD) are rapidly increasing public health problems in ageing populations and at the moment curative treatment is lacking. Thus, the putative protective effects of caffeine against dementia/AD are of great interest. Here, we discuss findings from the longitudinal epidemiological studies about caffeine/coffee/tea and dementia/AD/cognitive functioning with a special emphasis on our recent results from the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study. The findings of the previous studies are somewhat inconsistent, but most studies (3 out of 5) support coffee's favorable effects against cognitive decline, dementia or AD. In addition, two studies had combined coffee and tea drinking and indicated some positive effects on cognitive functioning. For tea drinking, protective effects against cognitive decline/dementia are still less evident. In the CAIDE study, coffee drinking of 3-5 cups per day at midlife was associated with a decreased risk of dementia/AD by about 65% at late-life. In conclusion, coffee drinking may be associated with a decreased risk of dementia/AD. This may be mediated by caffeine and/or other mechanisms like antioxidant capacity and increased insulin sensitivity. This finding might open possibilities for prevention or postponing the onset of dementia/AD.
Similar articles
-
Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study.J Alzheimers Dis. 2009;16(1):85-91. doi: 10.3233/JAD-2009-0920. J Alzheimers Dis. 2009. PMID: 19158424
-
Caffeine and coffee as therapeutics against Alzheimer's disease.J Alzheimers Dis. 2010;20 Suppl 1:S117-26. doi: 10.3233/JAD-2010-091249. J Alzheimers Dis. 2010. PMID: 20182037 Review.
-
Diet and Alzheimer's disease risk factors or prevention: the current evidence.Expert Rev Neurother. 2011 May;11(5):677-708. doi: 10.1586/ern.11.56. Expert Rev Neurother. 2011. PMID: 21539488 Review.
-
Caffeine, diabetes, cognition, and dementia.J Alzheimers Dis. 2010;20 Suppl 1:S143-50. doi: 10.3233/JAD-2010-091228. J Alzheimers Dis. 2010. PMID: 20182038 Review.
-
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review.J Nutr Health Aging. 2015 Mar;19(3):313-28. doi: 10.1007/s12603-014-0563-8. J Nutr Health Aging. 2015. PMID: 25732217 Review.
Cited by
-
Targeting protein aggregation using a cocoa-bean shell extract to reduce α-synuclein toxicity in models of Parkinson's disease.Curr Res Food Sci. 2024 Oct 24;9:100888. doi: 10.1016/j.crfs.2024.100888. eCollection 2024. Curr Res Food Sci. 2024. PMID: 39525389 Free PMC article.
-
Optical Coherence Tomography Angiography: Investigating Vessel Density Changes Induced by Caffeine in Healthy Subjects.J Ophthalmol. 2024 Oct 28;2024:5597188. doi: 10.1155/2024/5597188. eCollection 2024. J Ophthalmol. 2024. PMID: 39502492 Free PMC article.
-
Astrocyte ryanodine receptors facilitate gliotransmission and astroglial modulation of synaptic plasticity.Front Cell Neurosci. 2024 May 14;18:1382010. doi: 10.3389/fncel.2024.1382010. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38812795 Free PMC article.
-
Exploiting Natural Niches with Neuroprotective Properties: A Comprehensive Review.Nutrients. 2024 Apr 26;16(9):1298. doi: 10.3390/nu16091298. Nutrients. 2024. PMID: 38732545 Free PMC article. Review.
-
A Systematic Analysis of the Correlation between Flavor Active Differential Metabolites and Multiple Bean Ripening Stages of Coffea arabica L.Molecules. 2023 Dec 28;29(1):180. doi: 10.3390/molecules29010180. Molecules. 2023. PMID: 38202762 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
